Media stories about Zoetis (NYSE:ZTS) have been trending somewhat positive recently, Accern reports. Accern ranks the sentiment of media coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Zoetis earned a media sentiment score of 0.18 on Accern’s scale. Accern also assigned headlines about the company an impact score of 45.893881224019 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
These are some of the news stories that may have impacted Accern Sentiment Analysis’s scoring:
Several analysts have recently issued reports on the company. BMO Capital Markets set a $78.00 price objective on Zoetis and gave the stock a “hold” rating in a report on Monday, January 22nd. Zacks Investment Research raised Zoetis from a “hold” rating to a “buy” rating and set a $71.00 price objective on the stock in a report on Thursday, October 12th. Craig Hallum reaffirmed a “buy” rating and set a $85.00 price objective (up from $77.00) on shares of Zoetis in a report on Tuesday, January 2nd. Cantor Fitzgerald set a $85.00 price target on Zoetis and gave the company a “buy” rating in a report on Tuesday, January 2nd. Finally, BidaskClub lowered Zoetis from a “hold” rating to a “sell” rating in a report on Wednesday, November 1st. Two analysts have rated the stock with a sell rating, four have given a hold rating and fourteen have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $73.72.
Shares of Zoetis (ZTS) opened at $76.00 on Monday. Zoetis has a 12-month low of $52.00 and a 12-month high of $80.13. The firm has a market capitalization of $37,414.00, a PE ratio of 35.22, a P/E/G ratio of 1.69 and a beta of 1.06. The company has a debt-to-equity ratio of 2.45, a quick ratio of 1.95 and a current ratio of 2.80.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 1st. Investors of record on Friday, January 19th will be given a dividend of $0.126 per share. The ex-dividend date is Thursday, January 18th. This represents a $0.50 dividend on an annualized basis and a yield of 0.66%. This is an increase from Zoetis’s previous quarterly dividend of $0.11. Zoetis’s dividend payout ratio (DPR) is presently 26.32%.
TRADEMARK VIOLATION WARNING: This news story was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this news story on another site, it was copied illegally and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this news story can be read at https://www.dispatchtribunal.com/2018/02/05/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-zoetis-zts-share-price.html.
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.